BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23470075)

  • 1. Adiponectin: merely a bystander or the missing link to cardiovascular disease?
    Hatzis G; Deftereos S; Tousoulis D; Bouras G; Giannopoulos G; Anatoliotakis N; Tsounis D; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):139-63. PubMed ID: 23470075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic perspectives for adiponectin: an update.
    Li FY; Lam KS; Xu A
    Curr Med Chem; 2012; 19(32):5513-23. PubMed ID: 22876919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and cardiovascular disease: state of the art?
    Szmitko PE; Teoh H; Stewart DJ; Verma S
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
    López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
    Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the heart: the protective role of adiponectin.
    Caselli C; D'Amico A; Cabiati M; Prescimone T; Del Ry S; Giannessi D
    Pharmacol Res; 2014 Apr; 82():9-20. PubMed ID: 24657240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Markers of endocrine system and inflammation as prognostic risk factors of vascular complications of type 2 diabetes mellitus].
    Verbovoĭ AF; Morkovskikh NV
    Vestn Ross Akad Med Nauk; 2011; (3):37-42. PubMed ID: 21542374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin in diabetes mellitus.
    Xita N; Tsatsoulis A
    Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin, cardiovascular disease, and mortality: parsing the dual prognostic implications of a complex adipokine.
    Kizer JR
    Metabolism; 2014 Sep; 63(9):1079-83. PubMed ID: 25038728
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical implications of blood adiponectin in cardiometabolic disorders.
    Chang LC; Huang KC; Wu YW; Kao HL; Chen CL; Lai LP; Hwang JJ; Yang WS
    J Formos Med Assoc; 2009 May; 108(5):353-66. PubMed ID: 19443289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Functional Interplay between IGF-1 and Adiponectin.
    Orrù S; Nigro E; Mandola A; Alfieri A; Buono P; Daniele A; Mancini A; Imperlini E
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adiponectin signaling in metabolic syndrome and cancer.
    Scheid MP; Sweeney G
    Rev Endocr Metab Disord; 2014 Jun; 15(2):157-67. PubMed ID: 24019064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between adipose tissue and vasculature: role of adiponectin.
    Li FY; Cheng KK; Lam KS; Vanhoutte PM; Xu A
    Acta Physiol (Oxf); 2011 Sep; 203(1):167-80. PubMed ID: 21062420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin in renal disease--a review of the evidence as a risk factor for cardiovascular and all-cause mortality.
    Connelly PW; Ramesh Prasad GV
    Crit Rev Clin Lab Sci; 2012; 49(5-6):218-31. PubMed ID: 23216078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
    Gable DR; Hurel SJ; Humphries SE
    Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin and cardiovascular disease: response to therapeutic interventions.
    Han SH; Quon MJ; Kim JA; Koh KK
    J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adiponectin as an adipose tissue hormone and its role in the metabolic syndrome and cardiovascular disease].
    Pańkowska E; Szalecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):187-90. PubMed ID: 16232373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional and post-translational regulation of adiponectin.
    Liu M; Liu F
    Biochem J; 2009 Dec; 425(1):41-52. PubMed ID: 20001961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.